Multiple Myeloma Survival Rate With Stem Cell Transplant

Multiple myeloma isn t considered curable but symptoms wax and wane.

Multiple myeloma survival rate with stem cell transplant.

Stem cell transplant is commonly used to treat multiple myeloma. The widespread use of high dose therapy and autologous stem cell transplantation asct as well as the introduction of novel agents have significantly improved outcomes in multiple myeloma mm enabling long term survival. All things considered while the autologous transplant can make the myeloma go away for a period of time even years it does not cure the growth and inevitably the myeloma back. There can be a long period of dormancy that could.

Findings from a phase 3 clinical trial note that patients with multiple myeloma who receive upfront autologous stem cell transplant asct typically live longer without disease. Patients with multiple myeloma live longer without their disease progressing if they get a stem cell transplant compared with patients who received chemotherapy alone. We here analyze factors influencing survival in 865 newly diagnosed mm patien. In some cases a bone marrow or stem cell transplant is an option.

See drug therapy for multiple myeloma stem cell transplants sct can be autologous or allogeneic. A stem cell transplant replaces diseased stem cells with healthy ones and is often used to treat this form of cancer. The long term survival of people with multiple myeloma following autologous stem cell transplant has steadily improved since 1997 through with the introduction of new medicines a large review study reports. To protect them your doctor removes stem cells.

Before the transplant drug treatment is used to reduce the number of myeloma cells in the patient s body. Autologous stem cell transplantation autosct has an important role in the treatment of patients with symptomatic multiple myeloma mm. Multiple myeloma survival rate after stem cell transplant. The high doses of chemo or radiation used to treat a multiple myeloma relapse can kill the stem cells in your bone marrow.

For example if the 5 year relative survival rate for a specific stage of multiple myeloma is 60 it means that people who have that cancer are on average about 60 as likely as people who don t have that cancer to live for. A relative survival rate compares people with the same type and stage of cancer to people in the overall population. A person with multiple myeloma is likely to have a low blood count.